Tavapadon as Adjunctive Treatment for Parkinson Disease: The TEMPO-3 Randomized Clinical Trial - Quiz - MDSpire

Tavapadon as Adjunctive Treatment for Parkinson Disease: The TEMPO-3 Randomized Clinical Trial

  • By

  • Hubert H. Fernandez

  • Stuart H. Isaacson

  • Robert A. Hauser

  • Pinky Agarwal

  • William Ondo

  • Ariane Park

  • Daniel Kremens

  • Matthew Leoni

  • Sridhar Duvvuri

  • Cari Combs

  • Erica Koenig

  • Ih Chang

  • Gina Pastino

  • Stacey Tringali

  • Nicole Golonski

  • Raymond Sanchez

  • Linda Harmer

  • Joey Boiser

  • Cindy Zadikoff

  • Zoltan Mari

  • May 1, 2026

  • 0 min

Share

Original Source(s)

Tavapadon as Adjunctive Treatment for Parkinson Disease: The TEMPO-3 Randomized Clinical Trial

  • by Hubert H. Fernandez, Stuart H. Isaacson, Robert A. Hauser, Pinky Agarwal, William Ondo, Ariane Park, Daniel Kremens, Matthew Leoni, Sridhar Duvvuri, Cari Combs, Erica Koenig, Ih Chang, Gina Pastino, Stacey Tringali, Nicole Golonski, Raymond Sanchez, Linda Harmer, Joey Boiser, Cindy Zadikoff, Zoltan Mari

  • May 1, 2026

Related Content

Editorial: AI-powered advances in diagnosis and management of movement disorders

Regular Metronome, Fractal Metronome, and Music for Parkinson Gait

Influence of Genetic Predisposition and Environmental Factors on Dementia with Lewy Bodies: Intersecting Pathogenic Mechanisms